Putnam Investments LLC Abb Vie Inc. Transaction History

Putnam Investments LLC

$73 Billion
Q4 2023

A detailed history of Putnam Investments LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 3,350,980 shares of ABBV stock, worth $603 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

3,350,980

Previous 3,172,869 5.61%

Holding current value

$603 Million

Previous $473 Million 9.8%

% of portfolio

0.71%

Previous 0.74%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $24.5 Million - $27.6 Million	178,111 Added 5.61%	3,350,980 $519 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $58.6 Million - $67.8 Million	438,442 Added 16.03%	3,172,869 $473 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $15.4 Million - $19.2 Million	-116,131 Reduced 4.07%	2,734,427 $368 Million
Q1 2023 May 22, 2023	SELL	$144.61 - $166.54 $46.1 Million - $53.1 Million	-318,712 Reduced 10.06%	2,850,558 $454 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $9.37 Million - $11.2 Million	67,712 Added 2.18%	3,169,270 $513 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $48.9 Million - $56.1 Million	-364,224 Reduced 10.51%	3,101,558 $416 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $339 Million - $431 Million	-2,464,149 Reduced 41.55%	3,465,782 $531 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $19.5 Million - $24.2 Million	147,991 Added 2.56%	5,929,931 $961 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $1.15 Million - $1.45 Million	10,696 Added 0.19%	5,781,940 $783 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $620,631 - $704,509	5,833 Added 0.1%	5,771,244 $623 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $76.9 Million - $85.7 Million	731,262 Added 14.53%	5,765,411 $649 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $10.5 Million - $11.6 Million	102,885 Added 2.09%	5,034,149 $545 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $360,353 - $486,515	-4,477 Reduced 0.09%	4,931,264 $528 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $12.6 Million - $14.8 Million	147,122 Added 3.07%	4,935,741 $432 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $24.4 Million - $32.6 Million	332,028 Added 7.45%	4,788,619 $470 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $6.18 Million - $9.37 Million	95,840 Added 2.2%	4,456,591 $340 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $2.75 Million - $3.44 Million	38,143 Added 0.88%	4,360,751 $386 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $43.3 Million - $52.1 Million	687,740 Added 18.92%	4,322,608 $327 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $194 Million - $248 Million	2,953,331 Added 433.33%	3,634,868 $264 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $26.4 Million - $31.1 Million	342,477 Added 101.01%	681,537 $54.9 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $2.84 Million - $3.5 Million	36,495 Added 12.06%	339,060 $31.3 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $133,720 - $148,655	-1,504 Reduced 0.49%	302,565 $28.6 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $45.1 Million - $53.3 Million	-502,064 Reduced 62.28%	304,069 $28.2 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $37.2 Million - $49.8 Million	-404,513 Reduced 33.41%	806,133 $76.3 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $105 Million - $115 Million	1,174,799 Added 3277.26%	1,210,646 $117 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $2.5 Million - $3.2 Million	35,847	35,847 $3.19 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Account

Putnam Investments LLC Abb Vie Inc. Transaction History